The T cell repertoire of 59 patients with untreated tuberculosis was compared with that of 46 bacille Calmette-Guérin -vaccinated controls by assaying the proliferative responses to six permissively recognized peptides from the 16-, 19-, and 38-kDa molecules of Mycobacterium tuberculosis. A trend from higher to lower reactivity following this order: vaccinated controls ú lymph node disease ú localized extrapulmonary ú pulmonary ú pleural was seen for 4 of the peptides (P õ .03). The decreased response of blood lymphocytes from patients with pleural tuberculosis was partially accounted for by sequestration of peptide-responsive cells within the pleural fluid. Chemotherapy ''reversed'' the depressed proliferative responses of patients with pulmonary and pleural tuberculosis depending on the peptide origin, being greatest for peptides of 16 kDa, transient for those of 19 kDa, and least for those of 38 kDa. These data demonstrate antigen specificity in the decreased responsiveness of patients with tuberculosis.
Vaccination using bacille Calmette-Guérin (BCG) is only T cell counts [5] , reduce soluble interleukin (IL)-2 receptor levels [6] , change lipopolysaccharide (LPS)-induced monocyte partially effective in preventing tuberculosis [1, 2] . The reasons cytokine secretion [7] and adrenal androgen production [8] , for this are multiple. One possibility is that the antigenic speciincrease serum antibody levels [9] , and reverse skin test ''anficity and phenotype of CD4 / T cell response to this vaccine ergy'' [10] . The T cell response to distinct M. tuberculosis differs from that induced by infection by Mycobacterium tuberantigens during chemotherapy has not, however, been systemculosis. Such natural infection is clinically inapparent in the atically investigated beyond our preliminary data on the 38majority of cases, but in the minority of cases, the outcome is kDa antigen [11] . In this study, we have therefore compared the early development of primary or, later, postprimary disease the T cell proliferative responses of healthy BCG vaccine recipfollowing reactivation, which may be as long as 30 years after ients (vaccinated controls, VC) with those of patients with a infection [3] . Chemotherapy of tuberculosis is highly effective, wide clinical spectrum of untreated postprimary disease. The with a õ5% relapse rate [4] , and so any changes in the specificcompartmentalization of the T cell response in pleural disease ity and phenotype of T cell response occurring during chemoand the effect of chemotherapy on the proliferative and cytotherapy may reflect the expression of protective immunity. Chekine response of a subset of patients with pulmonary or pleural motherapy is known to result in an increase in peripheral CD4 / disease was reassessed during chemotherapy. Tuberculosis is characterized by a T cell response to a wide range of antigens [12] . In this study, we used six T cell-stimula- incorporation during the last 8 h of the culture. The lymphocyte stimulation index (SI) was calculated using the following forobserved in all patient groups compared with the VC group mula: average counts per minute (cpm) in the presence of anti-(figure 1). A trend was seen from higher to lower reactivity gen/average cpm in the absence of antigen. Statistical methods for the peptides of the 16-kDa antigen and, to a lesser extent, relying on the Poisson distribution have been used for the interin response to 19p61-80 and 38p65-83: VCs had the highest pretation of data of T cell proliferative assays when the expected values, followed by untreated patients with lymphadenitis increments (such as in peptide-stimulated PBMC cultures) are (LN), localized extrapulmonary infection (EP), pulmonary inlow [29] . However, we found we could use the conventional fection (UP), and pleural tuberculosis (PL) (in descending orlymphocyte SI, defining a cutoff value of 3 as positive. We der) (P õ .03 for the trend in every case). In the case of the investigated the reliability of this convention by comparing the 19p61-80, the trend was not as uniform, as no EP patient SI of a first proliferation assay against that of a second test up reacted to this peptide. No trend in the patient group was disto 1 year later in 7 VCs who remained healthy in the intervening cernible in response to 19p141-159 or 38p350-369, although period. While there was variation between assays, using a cutoff of an SI of ú3, there was an 89.7% chance of reproducing the response of the largest group (UP) was depressed compared the same positive or negative result in the second assay. We with that of VC (P Å .08 and 0.01, respectively). The frequency concluded that the cutoff value of 3 could therefore be used of response to PPD was not significantly different between with confidence.
groups, although the mean SIs did show a similar ranking (VC Cytokine production and assay. PBMC at 5 1 Effect of chemotherapy on the lymphocyte proliferation of was used as a positive control. Aliquots were removed at 4, 7, UP patients. We investigated whether chemotherapy could and 24 h for reverse transcription-polymerase chain reaction reverse the depressed proliferative response in UP patients (ta-(RT-PCR) analysis, and the supernatants for ELISA were harble 1). We tested 15 patients before and after a mean of 76 { vested at 48 h. For ELISAs, Maxisorp (Nunc) plates were coated 18 days of chemotherapy; 7 patients were tested a third time with 50 mL/well monoclonal murine anti-interferon (IFN)-g monoclonal antibody 1-DIK at 2.5 mg/mL (Mabtech; Nacka, after the completion of chemotherapy at 243 { 26 days. The Sweden), anti-IL-4 (mouse anti-human IL-4; Mabtech) at 1 net effect of chemotherapy was to increase the median response mg/mL, and anti-IL-10 (cat. no. 18551D; PharMingen, San to all the tested peptides (figure 2). Individual cases showed Diego) at 4 mg/mL. The blocked wells were incubated with 100 variable spreading patterns of antipeptide reactivity, with occa-mL of culture supernatant in duplicate for 4 h, washed 4 times, sional decreases as well as increases. There were marked differand incubated at room temperature for 1 h with 100 mL of ences in the extent of reversal, depending on the peptide. The biotinylated detection monoclonal antibody 7B-61 anti-IFN-g 2 peptides of 16 kDa were associated with a sustained increase at 1 mg/mL (Mabtech), mouse anti-human IL-4 at 0.5 mg/mL in reactivity to the end of chemotherapy. PPD and the 2 pep-(Mabtech), or rat anti-human IL-10 at 4 mg/mL (cat. no.
tides of 19 kDa showed an increase followed by a slight de-18562D; PharMingen). Heterodimeric IL-12 was assayed using crease. In response to 38p65-83, there was an increase followed a Quantikine ELISA kit (R&D Systems, Minneapolis). One by a decrease such that the SIs at the end of chemotherapy hundred microliters of streptavidin-peroxidase (1 mg/mL; Sigma, St. Louis) was added to each well and incubated for 45 were actually lower than before therapy, and little change in min; 6 final washes were followed by 150 mL of K-Blue subnet response to 38p350-369. The most significant increases in strate (ELISA Technologies, Lexington, KY) and then (50 mL) stimulation during therapy were in response to PPD (P õ .01), K-Red stop solution (ELISA Technologies) when the color de-16p21-40 (P Å .02), and 19p61-80 (P Å .04). velopment was optimal. The plates were read at 680 nm, and
Comparison of the proliferative response of PBMC and cells the cytokine concentration in each sample was calculated with from PFC. We investigated the possibility that the particureference to the standard curve. The sensitivity of each ELISA larly depressed PBMC response of patients with untreated pleuwas as follows: IFN-g, 1 pg/mL; IL-4, 10 pg/mL; IL-10, 10 ral tuberculosis (figure 1) was due to sequestration of repg/mL; and IL-12, 10 pg/mL. sponding lymphocytes in the PFC. cussed above. In an exceptional instance (patient no. 6), when 4 was detected by either ELISA or RT-PCR, and levels of ILthe PFC were sampled twice, the initial repertoire was different 12 p70 were found to be negligibly low by ELISA (data not in PBMC and PFC, and after 23 days of treatment, the repershown). toire in both compartments widened but without overlap.
IFN-g and IL-10 production by PPD-stimulated PBMC. IFN-g and IL-10 secretion was tested in 8 and 7 tuberculosis Discussion patients, respectively, before and after 39 { 8 days (mean { SE) of treatment ( figure 4 ). This response was compared with
The depression of proliferative responses of PBMC to mycobacterial antigens in patients with active tuberculous disease that of 13 (10 for IL-10) VCs. Striking individual variation in IFN-g levels before and after chemotherapy lowered statisti-has been documented in a number of studies by others [30 -32] . Our main interest has been to investigate whether the cally significant differences (figure 4): 6 of 8 patients had an increase during therapy, but 2 initially high responding patients degree of this depression is associated with the specificity of CD4 / T cells using permissively recognized 20-mer peptides had a slight decline. The unstimulated production of IL-10 in patients was high before (126.8 { 68.0 pg/mL) and after (301.2 from M. tuberculosis complex antigens [16, 18, 28] . CD8 / responses to peptides in human tuberculosis have been difficult { 72.8 pg/mL) therapy compared with that of VCs (19.2 { 43.6 pg/mL, P Å .66 and .09, respectively). PPD-stimulated to detect even using peptides of optimal length conforming to known class I motifs [33] . While we have not formally ex-IL-10 production above the unstimulated level showed a pronounced decline following chemotherapy in 4 of 7 patients (P cluded them, we therefore consider that the 20-mer peptides used in this study, which are neither taken up nor processed, Å .028). In 5 patients tested before and during therapy, no IL-/ 9d50$$se02 07-28-98 06:49:38 jinfa UC: J Infect were unlikely to have elicited the proliferation of CD8 / T cells. ing chemotherapy. High intracytoplasmic expression of this protein is induced in stressed organisms [13, 15, 34] , and it is The results revealed marked differences in the frequency of peptide recognition depending upon the phenotype of disease possible that chemotherapy represents such a stress prior to bacterial killing, leading to reexpression and enhanced immu-ranging from 71% (16p21-40 in LN disease) to 0% (peptide 19p61-80 in EP disease) (figure 1). Even more striking were nogenicity of this antigen in treated patients. However, the quantitative levels of expression of this antigen might not pro-the differences in the extent to which the depressed proliferative response reversed, depending on the peptide, being the greatest vide the full explanation, given that antibody levels are known to decrease rapidly in fully treated patients but to increase in and sustained for peptides of the 16-kDa antigen, transient for those of the 19-kDa antigen, and least for those of the 38-kDa poorly compliant patients [21] . By comparison, the 19-kDa and 38-kDa glycoproteins are secreted by actively dividing bacilli antigen (figure 2). It is possible that a bias in peptide recognition could have arisen due to a more favorable HLA-binding [35] and, therefore, the level of secretion of both proteins might be expected to decrease rapidly during chemotherapy. This profile of particular peptides for the class II alleles expressed by the patients and controls studied. All subjects in this study interpretation is consistent with the transient increase in T cell reactivity but does not explain the depressed response in un-were HLA class II typed at DRB1* and DQB1* by the PCRsequence -specific primers method (data not shown). The allele treated patients ( figure 1) . The results indicate that this decreased response may be partially contributed to by sequestra-frequencies obtained were compared with the HLA binding profile of the peptides ([17]; Jurcevic S, Wilkinson RJ, unpub-tion of cells at sites of active disease ( figure 3) . Another possibility is that T cells responding to the peptides are not lished observations), and no evidence of such bias was apparent.
expanded by natural infection, due to failure of infected antigen-presenting cells to present antigen. Pertinent in this respect Ideally, a group of non -BCG-vaccinated primary-infected controls who had remained healthy for several years should are the observations that live mycobacteria growing in human macrophages are sequestered from recognition by CD4 / T cells have been studied in addition to those who had received BCG vaccination, as classification on the latter basis reflects at best
[36] and inhibit MHC class II presentation [37] . The observed high degree of decreased PBMC response in an incomplete immune phenotype. However, it is possible that important differences exist between the distinct antigens in patients with pleural disease correlates with a previous finding of high antibody levels in patients with tuberculous effusions their contribution to protective immunity. The relatively high frequency of response to the two peptides of the 16-kDa antigen [9] and reflects the generally perceived reciprocal relationship between levels of T cell and humoral immunity. The patients is associated with the contained, less severe disease phenotypes (LN and EP) and also with the best recovery of response follow-we studied had extensive postprimary pleural tuberculosis, / 9d50$$se02 07-28-98 06:49:38 jinfa UC: J Infect in PPD-induced IFN-g production in patients with pulmonary which is known to involve a selective concentration of CD4 / tuberculosis compared with VCs, confirming previous findings cells in the effusion [38] and could conversely lead to a reduc- [22] . In 6 patients with an initially low IFN-g response, there tion in circulating CD4 / T cells in peripheral blood, as found was an increase following therapy. In a similar study, housein patients with active pulmonary tuberculosis [5] . We considhold contacts of tuberculosis patients had higher secretion than ered that recirculation of activated cells from effusions followuntreated patients [42] . This apparent contradiction is probably ing treatment could increase the PBMC response during chemoexplained by the difference in control groups, as household therapy. Evidence in favor of this hypothesis was obtained in contacts (unlike our controls) would have a high probability 3 of 6 cases, whose T cell repertoire was found to be clearly of recent exposure. wider in PFC than in PBMC. However, in other cases the Small numbers of IL-4 -secreting cells in patients with tubertwo repertoires showed only minor overlap and, additionally, culosis were reported using the highly sensitive ELISPOT a spread of PBMC recognition during treatment to peptides not method [22] . Using the same technique, El Ghazali et al. estioriginally recognized by T cells of the disease compartment mated the numbers of PPD-responsive IL-4 -producing cells was seen. Therefore, the determinant spreading during treatin peripheral blood to be on the order of 1/100,000 [43] . In ment occurs not simply as a result of recirculation of cells from this study, in a smaller number of patients, we were unable to the disease compartment, and other mechanisms, such as the obtain positive IL-4 values by either ELISA or RT-PCR. Others production of antiinflammatory cytokines or altered antigen have reported IL-4 gene expression in PBMC without detecting presentation or recognition, may also play a role.
secretion of IL-4 by ELISA [44, 45] . However, our present data It is widely believed that IFN-g is protective in tuberculosis support the view that IL-4 production in human tuberculosis is [39 -41] . In this study, we did not find a significant diminution not pronounced [46 -48] and that other cytokines probably / 9d50$$se02 07-28-98 06:49:38 jinfa UC: J Infect drive both the antibody response and depressed T cell prolifera-An important practical point of this work is that studies on T cell responsiveness need to differentiate treated from untreated tion. IL-10 may be important in this respect. We found that IL-10 was produced without antigen stimulation by PBMC patients. Thus the lack of posttreatment recovery of response to 38p350-369 explains the previously reported peptide-specific from tuberculosis patients (perhaps reflecting macrophage activation) and that the additional increment caused by PPD stimu-anergy [28] . In conclusion, the decreased responsiveness of PBMC in patients with tuberculosis seems to be contributed lation was only consistently demonstrable in untreated patients (figure 4). Our findings are consistent with the observation that to by a number of factors. Sequestration of cells at the site of the disease and a shift in cytokine production by PBMC, IL-10 down-regulates M. tuberculosis -induced Th1 responses and CTLA-4 expression [49] and can depress the proliferative particularly of IL-10, are undoubtedly involved. Some of these differences resolve during chemotherapy, and the cytokine pro-response of patients and controls [32, 42] . A prominent role in the depressed proliferative response has also been attributed duction by patients tends towards that of PPD-positive controls, though some differences in peptide recognition remain. A num-to the monocyte production of transforming growth factor-b [42] , which enhances macrophage ability to produce IL-10 ber of mycobacterial antigens are candidates for prophylactic vaccination [27, 55 -57] . Our data contribute to the better un- [50] , but the possibility that IL-10 and transforming growth factor-b may act synergistically in their effects on T cells has derstanding of the fine specificity of the T cell response and could be valuable in the design and further evaluation of such not been investigated.
We did not detect any bioactive IL-12 p70 by ELISA, per-protective subunits. haps because IL-12 production can be better stimulated by live or dead M. tuberculosis [51, 52] , and this secretion requires
